Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

calaspargase pegol

calaspargase pegol
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Asparlas SOLUTION, INTRAVENOUS 750 units/mL      
Comments:

Restricted to Oncology

Pediatrics: Asparlas will primarily be used in pediatric patients (Oncaspar no longer to be used in pediatric patients).

Adults: Asparlas should only be used in adult patients > 21 years of age if Oncaspar is unavailable.

Reviewed: Nov. 2022 (Asparlas)

Last updated: Dec. 2, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved